|
Biotechnology Services
|
US$
100 |
|
Mar-2024 |
Doc　#39854 |
|
| Printed Page Length :
17
pages |
| Number of Tables :
1 |
| Number of Figures:
1 |
|
Market Overview
|
|
In 2024, Taiwan's biotechnology service industry is poised to navigate through a landscape marked by both challenges and opportunities. Fierce competition from established players in South Korea and China, delays in the clinical trial process for new drugs both domestically and abroad, and the high costs associated with obtaining key raw materials for manufacturing, suggest the industry's growth momentum may experience pressure.
|
|
|
|